For press inquiries click here to contact us.
Inscripta (Alumni)
Inscripta closes $150M VC round, scores first commercial buyer of CRISPR gene editing platform
Inscripta (Alumni)
Having shipped its first benchtop gene editing devices, Inscripta draws another $150M from deep investor well
Lyell Immunopharma
Lyell Completes Cutting-Edge $65 Million Cell Therapy Facility
Crossover Health, Inc. (Alumni)
Crossover Health banks $168M Series D
Genomics PLC
Oxford’s Genomics Pushing the Boundaries of Personalized Medicine
Genomics PLC
Entrepreneurs: Meet Genomics founder Sir Peter Donnelly as biotech firm takes DNA analysis trials to America
Color Health
Inside Color’s big — and highly bankrolled — pivot to public health tech
Everly Health
Everlywell acquires two healthcare companies and forms parent Everly Health
Maze Therapeutics
Exclusive: Maze unveils their $191M pipeline, taking on Vertex and two long-sought conditions
Please see important disclaimers in the Terms section.
